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ABSTRACT
T-helper (Th) 2 cells, which produce interleukin (IL)-4,
IL-5, IL-10 and IL-13 upon stimulation of their T cell
receptors, play an important role in the develop-
ment of human allergic diseases. However, the precise
mechanism involved in the differentiation of Th2 cells
is not well understood compared with that of Th1 cells.
The selective differentiation of Th1 or Th2 subsets is
established during priming under the influence of a
variety of factors. Prostaglandin E2 (PGE2) is one of
those factors. Prostaglandin E2 produced by antigen
presenting cells directly affects the naive CD4+ T cells,
causing them to differentiate into Th2 cells. This effect
is mediated by the elevation of cyclic adenosine
monophosphate (cAMP) at the early stage of T cell acti-
vation. IL-4 and PGE2 lead naive CD4+ T cells to
differentiate into Th2 cells cooperatively, by distinct
signal transduction. Both PGE2 and IL-4 inhibit the
hypomethylation of the proximal regulatory regions of
the genomic IFN-g gene, whose hypomethylation has
been suggested as being important for the IFN-g pro-
duction by CD4+ T cells stimulated through their
antigen receptors. Prostaglandin E2 facilitates Th2
differentiation of naive CD4+ T cells by acting not only
on T cells directly but also on antigen presenting cells
by inhibiting their IL-12 production. The production of
PGE2 by monocytes is increased significantly in allergic
patients. These results, taken collectively, suggest that
PGE2 plays an important role in facilitating the dif-
ferentiation of Th2 cells in vivo.
Key words: interleukin, naive CD4+ T cells, prosta-
glandin E2, T-helper 2 cells.
INTRODUCTION
The existence of two different subsets of CD4+ T cells was
demonstrated in mice by Mossman et al. in 1986 and has
also been reported in humans.1,2 In both mice and
humans, CD4+ T cells have been classified into a func-
tionally heterogeneous population with specific profiles of
cytokine production. T-helper (Th) 1 cells produce inter-
leukin (IL)-2, interferon (IFN)-g , and tumor necrosis
factor (TNF)-b . Th2 cells produce IL-4, IL-5, IL-10 and
IL-13. In the absence of definite differentiation to Th1 or
Th2 cells, the large majority of CD4+ T cells, which are
termed Th0, produce both Th1- and Th2-type cytokines.
These subsets are now considered to be involved in many
immunologic diseases.2 Because the naive CD4+ T cells,
which differentiate in the thymus and do not encounter any
antigen in the periphery, can produce primarily IL-2 upon
stimulation, the mechanism by which common naive
CD4+ T cells differentiate into these two different subsets
has become an important subject for many researchers.3
Wierenga et al. first reported that allergen-specific
CD4+ T cell clones in allergic patients produce IL-4 and
IL-5, but little IFN-g and IL-2 (Fig. 1).4 Although it has
been shown that the cytokine profiles of human memory
CD4+ T cells are often not mutually exclusive, various
studies have confirmed the tendency for allergen-specific
CD4+ T cells in allergic patients to show a high IL-4 to
IFN-g production ratio.2 The differentiation of Th2 cells,
which produce IL-4, IL-5, and IL-13, is the current focus
not only for immunologists but also for allergologists,
given that these cytokines play critical roles in the devel-
opment of allergic inflammation (Fig. 2).5
Clarifying the mechanism that induces the differentia-
tion of Th2 cells from naive CD4+ T cells in humans will
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result both in clarifying the mechanism that induces aller-
gic diseases and in finding a new strategy for preventing
the development of allergic diseases. The present review
focused on the role of PGE2 in the differentiation of Th2
cells from naive CD4+ T cells.
DERIVATION OF TH1 AND TH2 CELLS FROM
COMMON NAIVE CD4+ T CELLS
All human CD4+ T cells that have left the thymus and not
yet encountered their corresponding antigen have naive
phenotypes such as CD45RA on their surface. The cyto-
kine production profile of these naive CD4+ T cells has
been demonstrated as being confined mainly to IL-2.3
After primary stimulation thorough T cell receptor (TCR) in
vitro, these CD4+ T cells expressed a variety of cytokine
genes including IL-2, IL-3, IL-4, IL-5, IL-6, granulocyte-
macrophage colony stimulating factor (GM-CSF) and
IFN-g at secondary stimulation. One of the important
issues in Th1/Th2 differentiation is the clarification of
whether the two subsets are derived from two different
pools of precursor Th cells or a common precursor
cell. The establishment of transgenic mice, which have
a and b chains of T cell receptors that recognize known
antigen/major histocompatibility complex (MHC) class II
complexes, provided the answer. Many in vitro studies
demonstrated that common precursors of naive CD4+
T cells of these transgenic mice could differentiate into
both subsets of Th cells depending on the environmental
factors at primary stimulation.6,7
EFFECT OF EXOGENOUS AND ENDOGENOUS
IL-4 ON THE DIFFERENTIATION OF TH2 CELLS
From the initial studies of the differentiation of naive
CD4+ T cells, it was demonstrated that exogenous IL-4
at priming had a strong influence on naive CD4+ T cells,
causing them to differentiate into Th2 cells. This has led
many groups to search for the source of exogenous
IL-4 which can supply enough IL-4 to cause naive CD4+
T cells to differentiate into Th2 cells.8 The levels of serum
IL-4 in many atopic patients are too low to cause naive
CD4+ T cells to differentiate into Th2 cells.9 This finding
indicates that when exogenous IL-4 plays a role in the
differentiation of Th2 cells, it may have to exert its effect
in the micro-environment containing naive CD4+ T cells
to supply a sufficient concentration of IL-4 by an antigen-
driven bystander mechanism. This hypothesis further
suggests that IL-4-producing cells in those in vivo micro-
environments must be activated by the same or associ-
ated antigens at the same time as naive CD4+ T cells are
activated by those antigens.
To date, several cells have been nominated as the
source of exogenous IL-4. Candidates include CD4+
T cells bearing the NK1.1 surface marker, mast cells and
basophils.10–12 NK1.1+CD4+ T cells can produce IL-4
within 1 h upon stimulation by in vivo administration of
anti-CD3 antibody.13 Although the time course of IL-4
production by NK1.1+CD4+ T cells is appropriate for the
priming of naive CD4+ T cells, these cells are known
to have a small repertoire of T cell receptors, which
recognize limited antigens such as glycosylceramides
presented on CD1 molecules.14 There remains a ques-
tion of how these NK1.1+CD4+ T cells can respond or
recognize a wide variety of antigens existing outside of
them. For the other candidates, the physiologic stimuli
that can stimulate these IL-4-producing cells differ from
those of naive CD4+ T cells, which need crosslinking of
their surface Fc receptor by IgE or IgG antibodies and
nominal antigens. The source or mechanism that can
provide exogenous IL-4 at the site of activation of naive
CD4+ T cells and induce production of Th2-type cyto-
kines remains to be clarified.
However, several studies have demonstrated the
production of IL-4 by naive CD4+ T cells themselves.15–17
The addition of anti-IL-4 neutralizing antibody to primary
cultures decreases the production of IL-4 or IL-5 and
increases that of IFN-g by effector Th cells at secondary
stimulation.15,16 Furthermore, IL-4 can be detected in the
supernatants of stimulated naive CD4+ T cells in the
presence of anti-IL-4 receptor monoclonal antibody to
prevent binding of IL-4 to its receptors.17 These results
suggest that the very small amounts of endogenous
IL-4 produced by naive CD4+ T cells markedly affect the
cytokine producing profiles of Th cells.
Other factors, including the intensity and quality of
the TCR-mediated signals, costimulatory signals and
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Fig. 1 Cytokine production profiles of CD4+ T cells in aller-
gic patients. Allergen-specific CD4+ T cell clones in allergic
patients produce Th2-type cytokines.
hormones, are also reported to influence the differentia-
tion of naive CD4+ T cells. The various effects of these
factors, including cytokine environment, have been exten-
sively reviewed by Seder and Paul8 and Constant and
Bottomly.18 As the object of the present review is to sum-
marize the role of PGE2 in the differentiation of naive
CD4+ T cells into Th2 cells, it is recommended that the
reader refer to these reviews for more information con-
cerning these factors.
ROLE OF PROSTAGLANDIN E2 ON THE
DIFFERENTIATION OF NAIVE CD4+ T CELLS
Prostaglandins are produced by the action of the enzyme
cyclooxygenase on arachidonic acid liberated from
membrane phospholipids. Macrophages and follicular
dendritic cells, which are professional antigen presenting
cells, synthesize PGE2 as major products of arachidonic
acid metabolism.19,20 Prostaglandin E2 has a variety of
effects on many aspects of the immune system, such as
immunoglobulin synthesis by B cells and cytokine pro-
duction by macrophages and T cells.21–26 For cytokine
production of CD4+ T cells in particular, PGE2 inhibits the
production of Th1-type cytokines, such as IL-2 and IFN-g,
by committed Th1-type cells. However, it does not inhibit
IL-4 production by Th2-type cells.27–31
In our initial study, the effects of PGE2 on the differen-
tiation of naive CD4+ T cells from human umbilical cord
blood was reported.32 Purified naive CD4+ T cells from
human cord blood were stimulated with anti-CD3 mAb and
Fcg RII-transfected L cells in the absence of both antigen pre-
senting cells and exogenous cytokines, and expanded in an
IL-2-containing medium. These activated T cells produce
IL-2, IL-4, IL-5, and IFN-g upon stimulation with phorbol
12-myristate 13-acetate (PMA) and ionomycin. Prosta-
glandin E2 at the primary stimulation of naive CD4+ T cells
inhibits acquisition of ability to produce IFN-g and IL-2 but
not IL-4 or IL-5 in a dose-dependent manner. The mRNA
expression of IFN-g and IL-2, but not that of IL-4, was also
decreased. The addition of PGE2 during early T cell stimu-
lation was necessary for its maximal inhibitory effect on
Th1-type cytokine production. These results suggest that
PGE2 plays a role in facilitating the development of the
Th2-type cytokine production profile. As IL-12 produced
by antigen presenting cells induces the differentiation of
Th1 cells, PGE2 is also produced by professional antigen
presenting cells that have close cell-to-cell contact with
naive CD4+ T cells at primary stimulation, suggesting a
remarkable advantage of PGE2 as a Th2-inducing factor.
EFFECTS OF PGE2 ON THE CYTOKINE
PRODUCTION OF PRIMARY STIMULATION
It has been reported that at least some effects of PGE2 on
cytokine production by committed Th1 or Th2 clones
could be reverted by the supplementation of exogenous
IL-2.33 Prostaglandin E2 also inhibits IL-2 production by
naive CD4+ T cells stimulated with anti-CD3 and anti-
CD28.34 However, the decreased IL-2 production by
PGE2 at priming is not the cause of the skewed cytokine
production profile of CD4+ T cells because supplementa-
tion with exogenous IL-2 at priming does not revert the
skewing of the cytokine production profile by PGE2.34
When CD4+ T cells from human cord blood are
stimulated they produce very small amounts of IL-4 and
IFN- g . These small amounts of IFN-g or IL-4 markedly
affect the acquisition of the ability to produce cytokines
by naive CD4+ T cells.15,16 Prostaglandin E2 also inhibi-
ted IFN- g production at primary stimulation of naive
CD4+ T cells.34 The addition of exogenous IFN-g , at
priming, however, does not revert the skewing of the
cytokine production profile by PGE2, indicating that the
effect of PGE2 is independent of primary IFN-g produc-
tion by naive CD4+ T cells.32
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Fig. 2 Th1 and Th2 cells
are derived from common
naive CD4+ T cells. ?, The true
TH2 differentiation factor is
still unknown.
Prostaglandin E2 does not have a significant effect on
IL-4 production by naive CD4+ T cells at priming.34 In the
presence of anti-IL-4-receptor antibody at priming, the
acquisition of IL-4-, IL-5-, IL-10-producing ability was
remarkably inhibited while that of IFN-g and TNF-a was
enhanced. The inhibition of IFN-g -production by PGE2
did not revert after addition of anti-IL-4-receptor anti-
body, suggesting that the inhibitory effect of PGE2 for the
IFN-g -production is independent of IL-4 at priming.34
SIGNAL TRANSDUCTION BY PGE2 AND IL-4 IN
NAIVE CD4+ T CELLS
In many systems, the biological effects of PGE2 are
mediated by the increase in cAMP through its specific
receptors. The Th2-inducing effects of PGE2 on naive
CD4+ T cells at priming were also replaced by forskolin
or dibutyryl cAMP, which increase intracellular cAMP.32
These results indicate that PGE2 exerts its effect on naive
CD4+ T cells by the increase of cAMP at an early stage of
T cell activation.
IL-4 has also been reported to induce differentia-
tion of naive CD4+ T cells into Th2 cells.6,35 The signal
transducer and activator of transcription 6 (STAT6) has
recently been reported as playing a critical role in the
differentiation of Th2 cells by IL-4.36 However, studies of
signal transduction by IL-4 in normal human tonsillar
B cells also showed that IL-4 induced a sustained rise in
intracellular cAMP concentration.37 These results suggested
the possibility that the elevation of cAMP by IL-4 was
involved in the differentiation of naive CD4+ T cells into Th2
cells. Prostaglandin E2 increased the levels of cAMP in naive
CD4+ T cells which were stimulated via TCR; however,
IL-4 did not increase those levels 12 h after stimulation.38
Furthermore, Rp-diastereomer of adenosine cyclic 3¢, 5¢ -
phosphorothioate RpcAMP, which is a non-hydrolyzable
competitive inhibitor of cAMP, partially reversed the inhibi-
tion of IFN-g production by PGE2 but not by IL-4.38 These
results demonstrated that the signals transduced by IL-4
and PGE2, both of which result in the inhibition of the
priming for IFN-g production, are distinct. The results also
demonstrated that increased cAMP levels are not critical in
IL-4 signaling, at least in human naive CD4+ T cells.
By these distinct signal transductions, IL-4 and PGE2
at primary stimulation of naive CD4+ T cells have a
cooperative inhibitory effect on priming for IFN-g pro-
duction without having the remarkable effect on priming
for IL-4 production. As a result, the ratio of IL-4/IFN-g
remarkably increased following treatment with a low
concentration of both IL-4 and PGE2 compared to that
after single treatment with either agent alone, which did
not induce such a high IL-4/IFN-g ratio. The cooperation
of PGE2 and IL-4 may explain some of the reasons why
Th2 cells can be induced without high concentration of
IL-4 in vivo.
EFFECTS OF PGE2 AND IL-4 ON METHYLATION
OF THE 5¢ REGULATORY REGION OF THE
IFN-g GENE
For the differentiation of naive CD4+ T cells into Th2
cells, it is necessary that naive CD4+ T cells, which
produce mainly IL-2, acquire the ability to produce IL-4,
and that the expression of the IFN-g gene is kept in a sup-
pressed state. The production of IL-2 or IL-4 is controlled
primarily by the transient activation of the transcription
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Fig. 3 Role of prostaglandin
E2 and IL-4 in the differentia-
tion of naive CD4+ cells into
Th2 cells.
induced by the binding of corresponding nuclear factors
to the 5¢ flanking regions of the cytokine genes.39–41 The
acquisition of the IFN-g producing ability by naive CD4+
T cells may be more complex. As shown by studies using
the cell lines or different subsets of CD4+ T cells, both the
hypomethylation of the regulatory region of IFN-g gene
and the induction of the specific nuclear proteins which
bind to its regulatory region are involved in the acqui-
sition.42–44 As described, PGE2 and IL-4 provide naive
CD4+ T cells with distinct inhibitory signals for the
priming of IFN-g production. In order to compare and
analyze the molecular mechanisms by which PGE2 and
IL-4 inhibit the priming of IFN-g production, the effects of
PGE2 and IL-4 on the methylation of IFN-g gene during
in vitro differentiation of naive CD4+ T cells were investi-
gated by Southern blot analysis.45 In naive CD4+ T cells
from human cord blood, which primarily produce IL-2
and a small amount of IFN-g , the IFN-g gene was almost
completely methylated. After stimulation through TCR
in vitro, CD4+ T cells produced IFN-g at secondary
stimulation. The CpG dinucleotide contained within the
proximal regulatory element of the IFN-g gene, which is
currently thought to be a critical regulatory region for
stimulation-dependent IFN-g -production by T cells, was
partially hypomethylated.42,44–46 Both IL-4 and PGE2 at
priming of naive CD4+ T cells inhibited the hypomethy-
lation of this site and the acquisition of IFN-g -producing
ability. The addition of both factors at priming almost
completely inhibited the hypomethylation.45
Furthermore, 5-azacytidine, which inhibits methylation
of cytosine residue in DNA, restored the IFN-g -producing
ability of these cells treated with IL-4 and PGE2.45 These
findings suggest that, although the signal transduction
that inhibits the priming of IFN-g production differs for
PGE2 and IL-4, protection from hypomethylation of
the regulatory region of the IFN-g gene is involved in the
molecular mechanisms by which these factors inhibit
the priming of IFN-g production during the differentiation
of human naive CD4+ T cells.
Penix et al. reported that nuclear factors binding to the
regulatory element of the IFN-g gene in Jurkat extracts
were not detected in U937 or THP-1 extracts which did
not produce IFN-g .46 Regarding the T cell lineage, it
remains unclear whether these nuclear factors are
present in naive CD4+ T cells originally or are induced
during their differentiation into Th1 cells and whether
PGE2 and IL-4 inhibit the induction of these nuclear
factors as they inhibit the hypomethylation of the IFN-g
gene. Further studies on DNA methylation and the
nuclear factors necessary for IFN-g gene expression are
needed for the elucidation of the mechanism involved in
the differentiation of T helper cells.
PROSTAGLANDIN E2 AND IL-12 PRODUCTION
OF ANTIGEN PRESENTING CELLS
The professional antigen presenting cells, such as
monocytes and dendritic cells, not only produce PGE2
but also are affected by PGE2 itself.47 Prostaglandin E2
inhibits IL-12 production by monocytes, probably by
elevating intracellular cAMP. The b 2-agonist as well as
other cAMP-elevating reagents also inhibits IL-12
production by both monocytes in response to lipopoly-
saccharide (LPS) and dendritic cells stimulated through
CD40.48 Indeed, IL-12-deficient dendritic cells, which
are generated in the presence of PGE2, promote the
differentiation of Th2 cells from human naive CD4+
T cells.49 These results, taken together, suggest that PGE2
plays a critical role in facilitating the differentiation
of Th2 cells by affecting many aspects of immune res-
ponse (Fig. 3).
PROSTAGLANDIN E2 PRODUCTION IN ALLERGY
AND OTHER DISEASES
Chan et al. reported that the production of PGE2
by monocytes is increased in atopic patients and
suggested that this fact may be involved in the
altered cytokine production profile of atopic patients.50
Enhanced production of PGE2 by atopic patients’
monocytes was selective for PGE2 and not accom-
panied by enhanced production of IL-6, IL-10 or
IL-12.51 These findings suggest the possibility that
enhanced production of PGE2 by atopic patients’
monocytes might be involved not only in the regulation
of cytokine production by committed helper T cells, but
also in the differentiation of Th2 cells from naive CD4+
T cells in vivo. However, it should be kept in mind
that there is a possibility that these characteristics of
monocytes may be the result of the Th2-type cytokine
environment in patients having already developed the
allergic disease and not the cause of allergic diseases.
Still, it is likely that the enhanced production of PGE2 by
atopic patients’ monocytes is one of the exacerbating
factors in the development of allergic diseases.
In murine leishmaniasis in BALB/c mice, the Th2-type
cytokine production profile is involved in disease progres-
sion.52,53 Farrell and Kirkpatrick reported that the spleen
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cells of BALB/c mice that were infected with promastigotes
of L. major produced more than 10-fold higher concen-
trations of PGE2 than controls with the concomitant devel-
opment of systemic infection.54 However, the development
of both primary and metastatic lesions was dramatically
inhibited by oral administration of indomethacin.54 These
findings showed the involvement of endogenous PGE2
in the development of Th2-type cytokine production pro-
file in vivo.
CONCLUSION
Prostaglandin E2 favors the differentiation of Th2 cells
from naive CD4+ T cells by directly acting on naive CD4+
T cells and by inhibiting the production of IL-12 by antigen
presenting cells. The increased production of PGE2 by
allergic patients’ antigen presenting cells may be involved
in the development of Th2-type cytokine production
profiles. Further investigations regarding the mechanism
of Th2 cell differentiation, especially antigen specific
Th2 cells, will elucidate the mechanism of development of
human allergic diseases and may result in a new strategy
to inhibit the development of allergic diseases.
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